For its two-year mission, COBIOE will aim to support the European biomanufacturing sector by creating an interactive network of innovation actors and ecosystems working at all links in the biomanufacturing value chain: training, R&D, industrialization of processes and production, and through to such meta-aspects as regulations, health systems, sustainability, patient access, and more.
COBIOE has given itself three main missions. First, it will seek to identify and apprehend European actors in the biomanufacturing value chain for innovative therapies (e.g., gene and cell therapies) and biotech-produced medicines. Second, COBIOE will interconnect these entities, particularly as concerns isolated actors, to improve Europe-scale coverage (particularly via the analysis of potential complementarities and synergies). Third, the project will increase the visibility of the biomanufacturing value chain among stakeholders with the intention of engaging their cooperation and moving novel actors (academics, industrials, political deciders, investors, etc.) able to bring added value to the chain and support to the sector.
Genopole is the coordinator of COBIOE and furthermore responsible for the conceptualization of European value chains in biotherapies and tasked with communication to increase the network’s visibility and encourage actors in innovation to join it.
